ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
Petros Pharmaceuticals Inc

Petros Pharmaceuticals Inc (PTPI)

0.0943
-0.0096
(-9.24%)
Closed March 10 4:00PM
0.0931
-0.0012
( -1.27% )
Pre Market: 7:51AM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
0.0931
Bid
0.0931
Ask
0.0956
Volume
422,886
0.00 Day's Range 0.00
0.0731 52 Week Range 1.67
Market Cap
Previous Close
0.0943
Open
-
Last Trade Time
07:49:01
Financial Volume
-
VWAP
-
Average Volume (3m)
7,381,401
Shares Outstanding
10,014,872
Dividend Yield
-
PE Ratio
-0.07
Earnings Per Share (EPS)
-1.38
Revenue
5.82M
Net Profit
-13.81M

About Petros Pharmaceuticals Inc

Petros Pharmaceuticals Inc is a men's health pharmaceutical company. It focuses on identifying, developing, acquiring, and commercializing innovative therapeutics for men's health issues including erectile dysfunction, peyronie's disease, hormone health and substance use disorders. The company's ope... Petros Pharmaceuticals Inc is a men's health pharmaceutical company. It focuses on identifying, developing, acquiring, and commercializing innovative therapeutics for men's health issues including erectile dysfunction, peyronie's disease, hormone health and substance use disorders. The company's operating segment includes Prescription Medications and Medical Devices. It generates maximum revenue from the Prescription Medications segment. The Prescription Medications segment consists primarily of operations related to Stendra, which is sold generally in the United States, and H100 for the treatment of Peyronie's disease. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Wilmington, Delaware, USA
Founded
-
Petros Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker PTPI. The last closing price for Petros Pharmaceuticals was $0.09. Over the last year, Petros Pharmaceuticals shares have traded in a share price range of $ 0.0731 to $ 1.67.

Petros Pharmaceuticals currently has 10,014,872 shares outstanding. The market capitalization of Petros Pharmaceuticals is $944,402.43 . Petros Pharmaceuticals has a price to earnings ratio (PE ratio) of -0.07.

PTPI Latest News

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.0004-0.4278074866310.09350.11360.0731102295780.09669217CS
4-0.1757-65.36458333330.26880.650.0731152964930.18234916CS
12-0.2169-69.96774193550.310.650.073173814010.25329033CS
26-0.2627-73.83361439010.35580.650.073134346510.25767257CS
52-1.5469-94.32317073171.641.670.073119149590.31854354CS
156-12.8069-99.278294573612.928.80.073111883603.31706229CS
260-17.9069-99.48277777781859.5990.0731196430919.89378118CS

PTPI - Frequently Asked Questions (FAQ)

What is the current Petros Pharmaceuticals share price?
The current share price of Petros Pharmaceuticals is $ 0.0931
How many Petros Pharmaceuticals shares are in issue?
Petros Pharmaceuticals has 10,014,872 shares in issue
What is the market cap of Petros Pharmaceuticals?
The market capitalisation of Petros Pharmaceuticals is USD 944.4k
What is the 1 year trading range for Petros Pharmaceuticals share price?
Petros Pharmaceuticals has traded in the range of $ 0.0731 to $ 1.67 during the past year
What is the PE ratio of Petros Pharmaceuticals?
The price to earnings ratio of Petros Pharmaceuticals is -0.07
What is the cash to sales ratio of Petros Pharmaceuticals?
The cash to sales ratio of Petros Pharmaceuticals is 0.15
What is the reporting currency for Petros Pharmaceuticals?
Petros Pharmaceuticals reports financial results in USD
What is the latest annual turnover for Petros Pharmaceuticals?
The latest annual turnover of Petros Pharmaceuticals is USD 5.82M
What is the latest annual profit for Petros Pharmaceuticals?
The latest annual profit of Petros Pharmaceuticals is USD -13.81M
What is the registered address of Petros Pharmaceuticals?
The registered address for Petros Pharmaceuticals is CORPORATION TRUST CENTER, 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Petros Pharmaceuticals website address?
The website address for Petros Pharmaceuticals is www.petrospharma.com
Which industry sector does Petros Pharmaceuticals operate in?
Petros Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AWHAspira Womans Health Inc
$ 0.3716
(87.68%)
76.99M
TSVT2seventy bio Inc
$ 4.925
(75.89%)
1.12M
CUTRCutera Inc
$ 0.1924
(49.73%)
33.94M
SNOASonoma Pharmaceuticals Inc
$ 4.09
(46.59%)
17.33M
TNONTenon Medical Inc
$ 1.78
(42.40%)
12.25M
MBXMBX Biosciences Inc
$ 5.01
(-44.21%)
2
ARVNArvinas Inc
$ 10.85
(-38.21%)
263.44k
JANXJanux Therapeutics Inc
$ 20.05
(-33.65%)
40
SVRASavara Inc
$ 2.01
(-24.44%)
4
SNCRSynchronoss Technologies Inc
$ 6.01
(-22.45%)
4
AWHAspira Womans Health Inc
$ 0.3716
(87.68%)
76.99M
CUTRCutera Inc
$ 0.1924
(49.73%)
33.94M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
$ 7.77
(5.28%)
22.95M
SNOASonoma Pharmaceuticals Inc
$ 4.09
(46.59%)
17.33M
BTOGBit Origin Ltd
$ 0.4837
(1.81%)
15.09M

PTPI Discussion

View Posts
getmoreshares getmoreshares 3 days ago
reverse stock split of all of the outstanding shares of our Common Stock at a ratio in the range of 1-for-250 to 1-for-500, with such ratio

At the Special Meeting, we will ask stockholders to: (i) approve, for purposes of complying with Nasdaq Listing Rule 5635(d), the issuance of shares of our common stock, par value $0.0001 per share (the β€œCommon Stock”) underlying the Series A warrants (the β€œSeries A Warrants”) and Series B warrants (the β€œSeries B Warrants” and, together with the Series A Warrants, the β€œSeries Warrants”) issued by us in a public offering transaction on February 19, 2025 (including shares of Common Stock issuable upon operation of certain anti-dilutions provisions applicable to such Series Warrants, and shares of Common Stock issuable upon β€œalternative cashless exercise” feature in the Series B Warrants); (ii) approve an amendment to our Amended and Restated Certificate of Incorporation, as amended (the β€œCharter”), to effect, at the discretion of the Board but prior to the one-year anniversary of the date on which the reverse stock split is approved by the Company’s stockholders at the Special Meeting, a reverse stock split of all of the outstanding shares of our Common Stock at a ratio in the range of 1-for-250 to 1-for-500, with such ratio to be determined by the board of directors of the Company in its discretion and included in a public announcement; (iii) approve the Third Amendment to the Petros Pharmaceuticals, Inc. Amended and Restated 2020 Omnibus Incentive Compensation Plan, as amended, to increase the total number of shares of the Company’s Common Stock authorized for issuance under such plan by 1,000,000,000, to a total of 1,002,760,000 shares of Common Stock; (iv) approve an amendment to the Company’s Charter, to increase the number of our authorized shares of Common Stock from 250,000,000 shares to 7,000,000,000 shares and to make a corresponding change to the number of authorized shares of capital stock; and (v) approve a proposal to adjourn the Special Meeting to a later date or dates, if necessary or appropriate, to permit further solicitation and vote of proxies in the event that there are insufficient votes for, or otherwise in connection with, the approval of any one or more of the foregoing proposals.
πŸ‘οΈ0
0210 0210 3 weeks ago
PTPI cool cat...what gives? compared to 29-30 cents 1-week & 1-month VWAP...

https://ih.advfn.com/stock-market/NASDAQ/petros-pharmaceuticals-PTPI/historical
πŸ‘οΈ0
0210 0210 3 weeks ago
PTPI 13-14 cents vs. 24 cents latest public offer, hmmm...
https://www.tipranks.com/news/the-fly/petros-pharmaceuticals-prices-40m-shares-at-24c-in-public-offering?utm_source=edition.cnn.com&utm_medium=referral
πŸ‘οΈ0
glenn1919 glenn1919 3 weeks ago
PTPI...................https://stockcharts.com/h-sc/ui?s=PTPI&p=W&b=5&g=0&id=p86431144783
πŸ‘οΈ0
tw0122 tw0122 3 months ago

 Item 2.04 Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement. As previously reported in a Current Report on Form 8-K filed with the Securities and Exchange Commission on January 21, 2022, Metuchen Pharmaceuticals LLC (β€œMetuchen”), a wholly owned subsidiary of Petros Pharmaceuticals, Inc. (the β€œCompany”), entered into that certain (a) Settlement Agreement (the β€œSettlement Agreement”) and Security Agreement (the β€œSecurity Agreement”), each dated January 18, 2022, with Vivus LLC (the β€œSecured Party”) and (b) Promissory Note dated January 18, 2022, payable to the order of the Secured Party (the β€œPromissory Note”). As a result of an event of default under the Settlement Agreement and the Security Agreement existing and continuing by virtue of Metuchen’s failure to pay the Installment (as defined in the Promissory Note) that was due October 1, 2024, all the obligations of Metuchen under the Settlement Agreement and the Security Agreement (the β€œObligations”) became immediately due and payable on the date of the Foreclosure Notice (as defined below). As of December 10, 2024, the unpaid amount of the Promissory Note was $7,246,634.90 in principal and $237,300.35 in interest. Interest continues to accrue on the foregoing amount at the default rate of 9% per annum. Pursuant to the Security Agreement, the Secured Party holds a security interest against the Collateral (as defined in the Foreclosure Notice). On December 10, 2024, pursuant to a Notice of Proposal to Accept Pledged Collateral in Partial Satisfaction of Indebtedness Pursuant to Uniform Commercial Code Section 9-620 (the β€œForeclosure Notice”), the Secured Party proposed to accept all the Collateral (save and except the Specified License Agreement (as defined in the Security Agreement); collectively, the β€œForeclosed Collateral”) in partial satisfaction of the Obligations. The Secured Party further proposed in the Foreclosure Notice that its acceptance of the Foreclosed Collateral would only constitute satisfaction of $2,000,000 worth of the Obligations and would not include any other amounts outstanding under the Promissory Note, the Settlement Agreement, or the Security Agreement, including but not limited to (i) all interest accrued or at any time accruing thereon and (ii) all other sums recoverable by the Secured Party from Metuchen by virtue of the Obligations. On December 13, 2024, Metuchen accepted and agreed to the Foreclosure Notice.
πŸ‘οΈ0
tw0122 tw0122 3 months ago
Just viagra action .57 + 110% 
πŸ‘οΈ0
limer814 limer814 3 months ago
Any news?
πŸ‘οΈ0
tw0122 tw0122 3 months ago
.54 + 102% 
πŸ‘οΈ0
tw0122 tw0122 3 months ago
Where is everyone running nicely .50 
80% 
πŸ‘οΈ0
runncoach runncoach 10 months ago
Read the filings
πŸ‘οΈ0
shurtha2000 shurtha2000 10 months ago
Did $15M capital raise 10 months ago so cash should be no problem
👍️ 1
runncoach runncoach 10 months ago
Shocker...and some claimed nearly 2 years cash in the bank lol. Large debt on the books.
πŸ‘οΈ0
KeepItRealistic KeepItRealistic 10 months ago
Careful here …
https://stocktwits.com/KeepItRealistic/message/572708730
πŸ‘οΈ0
Monksdream Monksdream 11 months ago
PTPI new 52 week low
πŸ‘οΈ0
Monksdream Monksdream 11 months ago
PTPI new 52 lo
πŸ‘οΈ0
runncoach runncoach 11 months ago
We know what isn't up. Nasty
πŸ‘οΈ0
limer814 limer814 11 months ago
What's up
πŸ‘οΈ0
runncoach runncoach 11 months ago
Exactly
πŸ‘οΈ0
KeepItRealistic KeepItRealistic 11 months ago
New lows = new low conversion rates
πŸ‘οΈ0
runncoach runncoach 11 months ago
Likely nearing 8 million shares since another installment payment was due this week. Lost nearly 14 million dollars on less than 6 million in sales. Sales last year were lower than 2022. Patent expiring in 12 months. Lot's of other fun nuggets that most won't bother to read.
This one spells out further dilution it would seem:
Going Concern

Petros has experienced net losses and negative cash flows from operations since our inception. As of December 31, 2023, the Company had cash of approximately $13.3 million, positive working capital of $9.6 million, an accumulated deficit of approximately $98.9 million and used cash in operations during the twelve months ended December 31, 2023, of approximately $7.6 million. The Company does not currently have sufficient available liquidity to fund its operations for at least the next 12 months. These conditions and events raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date that these consolidated financial statements are issued.

GLTA
πŸ‘οΈ0
KeepItRealistic KeepItRealistic 11 months ago
$PTPI 10k filed

https://www.otcmarkets.com/filing/html?id=17418536&guid=11Q-knncHeK-B3h

β€œAs of March 26, 2024, the registrant had 6,875,814 shares of common stock outstanding.”
πŸ‘οΈ0
Monksdream Monksdream 11 months ago
PTPI under $2
πŸ‘οΈ0
Jess070283 Jess070283 12 months ago
FDA meeting tomorrow. Definitely swinging some shares for that IMO.
👍️ 1 ♥️ 1
wamuer wamuer 12 months ago
lots of pre market volume, looking good
πŸ‘οΈ0
wamuer wamuer 12 months ago
https://www.sec.gov/Archives/edgar/data/1815903/000110465924037906/tm249589d1_8k.htm
πŸ‘οΈ0
bman22 bman22 12 months ago
I'm in @ 485 shares. Let's go!
👍️ 1
wamuer wamuer 12 months ago
https://www.accesswire.com/844279/petros-pharmaceuticals-successfully-launches-ai-tool-in-collaboration-with-multi-billion-dollar-software-provider
👍️ 1
wamuer wamuer 12 months ago
there it is :))
👍️ 1
limer814 limer814 12 months ago
Come on ,let's get back in to the1.60s
👍️ 1
limer814 limer814 12 months ago
Well that's alot of premarket volume
👍️ 1
Backstabbed Backstabbed 12 months ago
Nice comeback
👍️ 1
wamuer wamuer 12 months ago
finally been held for so long
👍️ 1
limer814 limer814 12 months ago
Something is up
👍️ 1
wamuer wamuer 1 year ago
great ending
at its high :)))
πŸ‘οΈ0
limer814 limer814 1 year ago
Nice close 1.66
πŸ‘οΈ0
Backstabbed Backstabbed 1 year ago
$PTPI - love it
👍️ 1
limer814 limer814 1 year ago
Getting perky
πŸ‘οΈ0
Backstabbed Backstabbed 1 year ago
Nice
πŸ‘οΈ0
limer814 limer814 1 year ago
Well good morning $PTPI
πŸ‘οΈ0
Backstabbed Backstabbed 1 year ago
Yup! Moon mentioned it again yesterday
πŸ‘οΈ0
limer814 limer814 1 year ago
$PTPI These Bios are quiet until they are not. While you wait, you can watch this recent YouTube video with the Ceo. He has quite the experience with what he did in prior companies.https://t.co/80hPCoNPPk— Keith Rah (@keith_rah) March 6, 2024
πŸ‘οΈ0
limer814 limer814 1 year ago
BTC is at it again this am
πŸ‘οΈ0
KeepItRealistic KeepItRealistic 1 year ago
Avg volume (3m) is 907,606

So todays volume is inline with the average
πŸ‘οΈ0
Backstabbed Backstabbed 1 year ago
Is it just me? Or all liquidity went towards Crypto and Bitcoin
πŸ‘οΈ0
limer814 limer814 1 year ago
Added down here in the low 1.50s
πŸ‘οΈ0
limer814 limer814 1 year ago
I'm keep an eye for the news symbol on the app
πŸ‘οΈ0
KeepItRealistic KeepItRealistic 1 year ago
Volume down today
πŸ‘οΈ0
runncoach runncoach 1 year ago
No worries
πŸ‘οΈ0
KeepItRealistic KeepItRealistic 1 year ago
Yep
Your calculations were spot on !
Sorry for being in denial lol
πŸ‘οΈ0
runncoach runncoach 1 year ago
Now you see why I was approximating a million shares per month for these past 5 months. 8 more months to go
πŸ‘οΈ0